Niki BioSolutions, Inc. (NIKI) — Strategic Asset Allocation Index
Niki BioSolutions, Inc. (NIKI) has a Strategic Asset Allocation Index of 109.5% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $15.10 Million) total $15.10 Million, measured against net assets of $13.79 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Niki BioSolutions, Inc. to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Niki BioSolutions, Inc. Strategic Asset Allocation Index (2022–2025)
This chart shows how Niki BioSolutions, Inc.'s Strategic Asset Allocation Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 109.5%, representing strategic assets of $15.10 Million against net assets of $13.79 Million USD.
Annual Strategic Asset Allocation Index for Niki BioSolutions, Inc. (2022–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Niki BioSolutions, Inc. from 2022 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Niki BioSolutions, Inc. market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 109.5% | $15.10 Million | $- | $15.10 Million | $13.79 Million | ▼ -18.7 pp |
| 2024 | 128.2% | $15.10 Million | $- | $15.10 Million | $11.78 Million | ▲ +23.6 pp |
| 2023 | 104.7% | $16.10 Million | $- | $16.10 Million | $15.38 Million | ▼ -19.8 pp |
| 2022 | 124.4% | $9.74 Million | $- | $9.74 Million | $7.83 Million | — |